Delhi High Court today allowed Japanese pharmaceutical major Daiichi's plea against former Ranbaxy promoters Malvinder and Shivinder Singh and enforced Rs 35.62-billion arbitral award.
The arbitral award is also under challenge by Singh brothers in Singapore Court of Appeals.
Daiichi had approached the High Court last year to seek the enforcement of a Rs 25.62-billion Singapore arbitral award delivered in April 2016.
Daiichi had additionally claimed Rs 10 billion in interest and lawyers’ fees incurred in connection with the proceedings.
“Today’s judgment by the Hon’ble Delhi High Court has given partial success to some of the sellers of shares